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Mechanistic processes underlying human germline mutations remain largely unknown.Variation
in mutation rate and spectra along the genome is informative about the biological mechanisms.
We statistically decompose this variation into separate processes using a blind source separation
technique. The analysis of a large-scale whole genome sequencing dataset (TOPMed) reveals
nine processes that explain the variation in mutation properties between loci. Seven of these
processes lend themselves to a biological interpretation. One process is driven by bulky DNA
lesions that resolve asymmetrically with respect to transcription and replication. Two processes
independently track direction of replication fork and replication timing. We identify a mutagenic
effect of active demethylation primarily acting in regulatory regions. We also demonstrate that a
recently discovered mutagenic process specific to oocytes can be localized solely from population
sequencing data. This process is spread across all chromosomes and is highly asymmetric with
respect to the direction of transcription, suggesting a major role of DNA damage.
The superb accuracy of transmission of genetic information between generations is one
of the most fascinating properties of life. Infrequent errors in this transmission lead to
mutations that are the source of genetic variation which fuels evolution and causes genetic
disease. The key importance of mutagenesis motivated decades of experimental research
that revealed various modes of errors made by complex machineries of DNA replication
and DNA repair (1-3). In spite of this effort, biochemical mechanisms primarily responsible
for human germline mutation remain uncharacterized. Statistical analysis of massive whole
genome sequencing datasets in light of the knowledge accumulated by experimental genetics
and biochemistry offers a promising avenue of inquiry.

Author Manuscript

Studies of the origin of cancer somatic mutations have been propelled by the statistical
analysis of “mutation signatures” in cancer genomic datasets and by mapping these
signatures to known exposures to endogenous and exogenous mutagens (4-6). This analysis
exploits the trinucleotide context-dependency of mutation rate. Differential exposure of
tumors to mutagens serves as the main statistical instrument for the analysis. This approach
is not directly transferable to studies of human germline mutation because there is no analog
of the differential mutagen exposure, although some success was achieved by comparing
human populations (7-10).
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Here, we use variation along the genomic coordinate as the statistical instrument to
decompose human germline mutagenesis into independent biochemical processes. Human
mutation rate exhibits a modest but highly significant variation along the genome (11-13).
Our model assumes that several mechanistic processes generate human germline mutations.
These processes are characterized by types and context-dependency of nucleotide changes
and vary in their relative intensities along the genome (Fig. 1A). Mutational signatures
and the relative intensity of each process at each locus can be derived from the analysis
of DNA sequencing data alone. Slightly more formally, each process is characterized by
a relative preference for each of the 192 types of all possible single nucleotide mutations
in trinucleotide contexts oriented to the reference strand. Each process is assumed to vary
along the genome and the observed heterogeneity of mutational spectra between loci is
driven by different relative contributions of the processes (Fig. 1A). Inference of mutational
processes then represents a classical blind source separation problem that separates a set
of source signals from observed signal mixtures. For that, we devised a computational
approach that performs dimensionality reduction using Principal Component Analysis
(PCA) following by Independent Component Analysis (ICA) of mutational spectra in
reduced space, so that processes have independent spectra and each process may have either
positive (enrichment) or negative (depletion) preferences for context-specific mutation types
(Fig. S1A, see Methods). Although there could be different mathematical formulations of
a source separation problem, we argue that PCA-based dimensionality reduction following
by ICA-based spatial inference is both statistically powerful and biologically reasonable for
the population datasets considered here compared to the other state-of-the art approaches
(Fig. S1H, see Methods). Simulations show that, accounting for the size and properties of
the TOPMed dataset, our approach recovers processes that have a genome-wide contribution
of at least 0.1% of the overall mutation rate and spatial scale of at least 10kb (Fig. 1E).

Author Manuscript

As with any statistical procedure, the key question is whether a particular inferred process
reflects the biological reality or is a spurious signal. A powerful way to assess the biological
relevance of the inferred processes is provided by the symmetry between antiparallel
strands of DNA. Although DNA is a symmetric molecule, directional processes such as
transcription and replication break this symmetry. Mutational mechanisms coupled with
these processes are strand-dependent. For example, within genes A>G mutations are
depleted on the transcribed strand and enriched on the complementary non-transcribed
strand. This observation is attributed to the action of transcription-coupled repair (TCR)
(3, 14). All mutational mechanisms can be broadly classified into strand-dependent and
strand-independent.

Author Manuscript

Our statistical procedure assigns the direction of mutations with respect to the human
genome reference irrespectively of the direction of transcription, replication or double strand
break repair. For some genes the reference strand happens to be transcribed, while for
other genes it happens to be non-transcribed. As a consequence, in some genic regions
we will detect depletion of A>G mutations and in others we will detect depletion of its
complementary mutation T>C.
For a strand-dependent mutation process, our statistical procedure would infer two
independent components (Fig. 1B). Remarkably, these components can be easily identified
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as corresponding to the same underlying process because they would be exactly
complementary to each other. Following the example of mutation processes associated with
transcription, the intensity of A>G mutations in one of the components would be identical to
the intensity of T>C in the other. In contrast, a mutation process that is not strand-dependent
would generate a component that would be self-complementary (for example, the intensity
of A>G would be identical to the intensity of T>C). As a result, all biologically relevant
components would either be self-complementary or arise in mutually complementary pairs
(Fig. 1B-D).
We rely on this observation to test the biological validity of the inferred processes.
Motivated by the visual representation in Figure 1B,F, we called this test a “reflection test”.

Author Manuscript

We applied our method to a dataset of very rare single nucleotide variants (SNVs) from the
TOPMed freeze 5 (15) serving as a proxy to mutations (16). Overall, the dataset included
over 293 million SNVs with allele frequency below 10−4. To capture the regional variation,
we binned the genome into 264,291 non-overlapping windows of 10 kb, which is the
optimal scale for the number of inferred components (Fig. S1G)
ICA identifies 14 independent components that successfully pass the “reflection test”,
corresponding to 9 mutational processes, 5 of which are strand-dependent and the remaining
4 are strand-independent (Fig. 1F, Fig. S1C-E, Fig. S2). Almost all of these components
have the average bootstrap support at the level of 70-99% (Fig. S1D).

Author Manuscript

These 14 components are robust with respect to window size and are reproduced in the
independent gnomAD dataset (Fig. S1F). Finally, we validated these components using de
novo mutations identified by parent-child trio sequencing (17, 18). The spectra of de novo
mutations in loci dominated by a specific component show a high concordance with the
component spectrum inferred from the TOPMed dataset (Fig. S1K-M).
Eight of nine processes show notable and highly distinct correlations with genomic features
known to impact mutation rate, including gene bodies, replication timing, direction of
replication, and chromatin accessibility (Fig. 2A, Table S1). This strong association is
remarkable given that the statistical inference was totally agnostic with respect to features
other than mutation density.

Author Manuscript

Broadly, mutations can be introduced either as replication errors or as a consequence
of DNA damage. The hallmark of mutations induced by bulky DNA damage is strand
asymmetry with respect to direction of transcription (3, 19) and, as we recently argued,
direction of replication (20). Bulky DNA damage is resolved in a strand specific manner
within gene bodies due to the action of TCR (3, 21) and due to the preferential error-prone
damage bypass on the lagging strand during replication (2). Components 1 and 2 have
mutually complementary spectra and together correspond to a single strand-dependent
process (Fig. 1D, Fig. 2A, Fig. S1). The strand asymmetry of this process, measured as
the difference between intensities of components 1 and 2, strongly correlates with directions
of both transcription (r=0.32) and replication (r=−0.15). The sum of the two components
intensities reflects the overall regional activity of the process 1/2. For the process 1/2, it
correlates with replication timing (r=0.34). Components 1 and 2 correlate in strand specific
Science. Author manuscript; available in PMC 2022 June 22.
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manner with the experimentally obtained activity of the transcription coupled repair system
(21, 22) in a strand-specific way (Fig. S3). Collectively, these observations strongly suggest
that the process 1/2 is driven by the asymmetric resolution of bulky DNA damage.

Author Manuscript

In contrast, strand-dependent process 3/4 likely captures replication errors. The asymmetry
of this process strongly correlates with the direction of replication (r=0.31) but is
not meaningfully associated with any other epigenomic feature including direction of
transcription. Therefore, in contrast to process 1/2, this process is unlikely to be mediated
by bulky DNA damage. We hypothesize that process 3/4 reflects either a differential fidelity
between replicative polymerases or a differential efficiency of mismatch repair (MMR)
between leading and lagging strands (1, 23, 24). Although replication infidelity is frequently
assumed to be a major (or even leading) factor in germline mutagenesis (25, 26), process
3/4 offers the first probable genomic footprint of replicative errors. Interestingly, process 3/4
(sum of intensities of components 3 and 4) does not appreciably correlate with replication
timing, even though many other processes do.

Author Manuscript

Process 5 most closely tracks replication timing (r=0.54), showing greater intensity in
late-replicating regions. The association of germline mutation rate with replication timing
was noted a decade ago, but it was shown to be quantitatively weak (13, 27). A recent
study reported that the association is much stronger for C>A mutations (28). C>A mutations
are indeed enriched in process 5, although this enrichment is limited to TpCpN sequence
contexts. Unlike other processes, process 5 affects all mutation types in the same direction
(all types have positive values in the spectrum). This process is responsible for the
largest fraction of mutation rate variation along the genome (Fig. 2A). In spite of these
observations, the interpretation of this process is not straightforward because replication
timing itself is correlated with many epigenomic features. Interestingly, most other processes
are associated with replication timing, not only to a weaker degree, but also in the opposite
direction (Fig. 2A). This counteracting effect explains the weakness of the association
between overall mutation rate and replication timing.

Author Manuscript

Strand asymmetric process 6/7 is dominated by C>G transversions and is characterized
by strong local spikes totaling 265 Mb throughout the genome (Figure 3A-C). Analysis
of de novo mutations within these regions reveals that they are dramatically enriched in
mutations of maternal origin (Table S2). Several genomic regions with high prevalence of
maternal mutations, many of them occurring in clusters, have been reported by the original
trio sequencing studies (29, 30). Spikes of process 6/7 include all these regions and many
previously unreported regions, also strongly enriched in individual and clustered mutations
of maternal origin (Table S2 and Table S3). Overall, the rate of clustered maternal de novo
mutations in regions of high intensity of process 6/7 is 18-fold higher than in the rest of the
genome. These regions constitute 10% of the genome but harbor 67% of clustered maternal
mutations (Fig. 3D, Table S3). Mutations in high intensity regions of process 6/7 have
stronger dependence on maternal age and are responsible for 35% of mutations caused by
oocyte aging. Mutations within these regions show a 2.6-fold excess in children of older
mothers compared to younger mothers (Fig. 3H). In the remaining 90% of the genome this
excess is just 1.4-fold. In contrast to earlier reports, this difference is not limited to C>G
mutations (30).

Science. Author manuscript; available in PMC 2022 June 22.

Seplyarskiy et al.

Page 8

Author Manuscript

Five prominent spikes of process 6/7 overlap long fragile genes (WWOX, RBFOX1,
CSMD1, FHIT, SDK1) (31). In these and other genes, process 6/7 displays a strong strand
asymmetry with respect to transcription (Fig. 3, Fig S4, Fig S5; r=0.26). Within the gene
bodies as compared to flanking regions, the rate of C>G mutations is decreased on the
transcribed strand and is increased on the non-transcribed strand by as much as 50-200%
(Fig. 3, Fig. S5).

Author Manuscript

Maternal mutations accumulate in oocytes that are arrested in the second phase of meiosis
from the early stages of embryogenesis. Thus, the age-related increase of maternal mutations
is unlikely to be explained by replication errors. Alternative mutation mechanisms should
involve either DNA damage or resolution of double strand breaks outside of S-phase. The
latter is favored by the current literature (29, 30). This is an appealing explanation in light
of mutation clusters and the striking maternal age dependency resembling the impact of age
on structural variants (32). This is consistent with our observation that process 6/7 overlaps
genes with common fragile sites. At the same time, the directly established spectrum of
mutations induced by recombination has no sign of enrichment in C>G and is very different
from process 6/7 (18). Furthermore, the signature of homology repair deficiency in cancer
genomes also has a very different spectrum (4).

Author Manuscript

The strand asymmetry of process 6/7 cannot be easily explained by the double strand break
model. The reduction of mutations on the transcribed strand suggests the role of bulky
DNA damage repaired by TCR. In addition, the relationship with direction of replication
(r=0.14, Fig. 2A, Fig. S4A) probably indicates that the unrepaired lesions on the leading
and lagging strands are asymmetrically converted into mutations at the very first division
of the zygote. The most surprising observation is the increase of mutation rate on the
non-transcribed strand. Transcription-associated mutagenesis (TAM) has been previously
reported in lower organisms and in some cancer types (19, 33). Our analysis identifies
TAM in human oocytes and shows that it is primarily localized to bursts of the process 6/7
(Fig. 3G, Fig. S5). TAM is a strand-dependent process associated with transcription and is
unlikely to be explained by double strand break repair. Collectively, these observations, point
to the localized susceptibility to DNA damage or the failure of DNA repair.

Author Manuscript

Processes 8 and 9 are dominated by mutations in the CpG context. Process 8 is characterized
by CpG transitions and describes a well-known mechanism of spontaneous deamination
of methylated cytosines which converts them into thymines. As expected, the intensity
of process 8 is positively correlated with methylation levels and is low in CpG islands
marking actively demethylated regulatory elements. Process 9 is characterized by CpG
transversions. The intensity of this process spikes at CpG islands and is negatively correlated
with methylation level (Fig. 4). CpG transversions were previously shown to be positively
associated with the level of cytosine hydroxymethylation (34). Based on high intensity in
CpG islands, the negative correlation with methylation level and the positive correlation with
hydroxymethylation level, we hypothesize that process 9 is caused by active demethylation
of regulatory regions. Enzymatic demethylation is initiated by oxidation of a methylcytosine
resulting in a hydroxymethylcitosine (35). The hydroxymethylcitosine base, following
cycles of subsequent oxidation, is removed by the Base Excision Repair system (BER),
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creating an abasic site. Unfinished repair of abasic sites is known to result in C>G mutations
(36).
Process 9 explains a small portion of the mutation rate variability. However,
it disproportionately contributes to regulatory regions of the human genome. In
undermethylated regions, the rate of CpG transversions is elevated under ChIP seq peaks
for transcription factors (Figure 4). The mutagenic effect of repair of hydroxymethylated
cytosines has been shown previously (34). We identify this process in an unsupervised
manner and attribute it to unintended side effect of the functionally significant
demethylation. In line with our model, cadmium, that suppresses cytosine demethylation,
leads to depletion of C>G mutations in daphnia (Supplementary Manuscript).

Author Manuscript

The only remarkable association between intensity of process 10/11 and genomic features
is a weak spike at the transcription end site on the transcribed strand of the gene (Figure
2E). Potentially this process is associated with transcription termination, but this localized
effect is diluted at the 10 KB scale. The remaining processes 12/13 and 14 explain small
proportions of the mutation rate variation. Statistical analysis of these processes does
not unequivocally suggest specific biological mechanisms (see Supplementary Note for
discussion of these processes).
Our analysis was enabled by the massive scale of the TOPMed dataset. Subsampling of the
dataset shows that many components would not be detectable in smaller datasets. Even at
the TOPMed scale, there are no statistical signs of saturation for the number of detectable
processes (Fig. S1I-J) and a notable range of mutational processes remains undetectable in
current settings (Fig. 1E). We hypothesize that larger population sequencing datasets are
needed to paint a more detailed picture human germline mutagenesis.

Author Manuscript

In sum, our unsupervised statistical analysis of the genomic variation in mutation rate
evident in population sequencing data implicates a compendium of biological processes
responsible for human mutation. Our approach identifies a highly localized strand-dependent
process dominated by mutations of maternal origin. This process tracks direction of
transcription, suggesting a dominant role of transcriptionally-mediated damage in oocytes.
We also characterize a mutation signature of replication errors, which has been historically
suspected to be a major source of germline mutation. We attribute mutagenic patterns of
repair of hydroxymethylated cytosines (34) to active demethylation of regulatory regions.
We envision that a spatial mutational model applied to new datasets will uncover new links
between DNA biochemistry and localized mutational patterns.

Author Manuscript

Material and Methods.
Preparation of mutational matrix
As a proxy for germline mutations, we used SNVs with allelic frequency below 10−4
from TOPMed freeze 5 (1) or gnomAD (2). The genome was binned into non-overlapping
windows of 2, 5, 10, 30, 100 or 1000 kilobases in size, and mutation rate within each
window was estimated as a ratio between the number of mutations and the number of
available sites. To explore uniformity of the calling/sequencing quality, we obtained the
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distribution of the number of mutations within 1 kb windows across the genome. This
distribution was bimodal with the first mode equal to 0 SNVs per region (Fig. S1A). This
mode clearly corresponded to regions of low quality. Therefore, we excluded 1kb loci
with the abnormally low mutation counts (less than 50 mutations) from all subsequent
analyses. Overall, our results were stable with respect to different filtering thresholds (data
not shown).
Inference of mutational components
Mutation rates for each mutation type were Z-score transformed across all windows to zero
mean and unit standard deviation. Using a predefined number of components n, matrix R
of transformed mutation rates in w=264’291 windows of t=192 mutation types was then
factorized by singular value decomposition using the R package svd:

Author Manuscript

Rw × t = Uw × n ⋅ Λn × n ⋅ V n × t

(1)

Matrix Vn×t of loadings of mutation types onto first n principal components was then
centered to zero mean of columns V^n,t = Vn,t – ⟨V⟩n, and rotated to infer statistically
independent residual spectra components M^n×t using the independent component analysis
(ICA) R package icafast:
V ∧ n, × t = Sn × n ⋅ M ∧ n × t

Components spectra were then defined as:

Author Manuscript

Mn, t = M ∧ n, t + (S−1)n, t ⋅ 〈V 〉n

Since ICA defines components up to a sign and scalar, signs of rows of M were oriented to
enable positive third moment and scales of rows were normalized to unit Euclidean norm.
Oriented matrix Mn,t was considered as a matrix of normalized loadings of mutation types
on components, while the matrix of intensities of mutational components in windows was
estimated as: I = U · Λ · S. Altogether, matrix Rw,t of transformed mutation rates was
factorized into a product of intensities Iw,n and independent spectra Mn,t of n mutational
processes:R=I · M.

Author Manuscript

The spearman correlation coefficient was estimated between the spectrum and reverse
complementary spectrum of each pair of components and with itself (we call it reflection
correlation). Components having a reflection correlation more than 0.75 with at least one
component were considered having reflection, or were otherwise considered to be noise.
Inferred components were then classified into strand-independent, strand-dependent pairs
or noise using the reflection test. Among components with reflection, components having
a reflection correlation of more than 0.75 to itself were considered strand-independent.
Pairs of components having a reflection correlation with each other were considered as two
components of a strand-dependent process. Empirical observations show that a cutoff of 0.75
falls in a wide interval of values that deliver the same classification of components.
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Since the reflection property of a component likely indicates its biological relevance,
we used the number of components having reflection as a natural criterion to choose a
predefined number of inferred components n: the number of components with reflection was
estimated for the range of values of n from 2 to 50, and the value of n corresponding to
the highest number of components with reflection was selected. The procedure identified
that the maximum number of mutational components with reflection is 14 for 10kb genomic
windows.
As a first step Rwxt matrix was factorized on 14 components (n=14) with svd. Than to select
the optimal window size, the algorithm was applied for a range of windows from 2 kb to
1 mb (2, 5, 10, 30, 100, 1000 kilobases) using these 14 input components. The number of
components with reflection (Spearman correlation > 0.75) was estimated for each window
size. Only window of 10 kb had all 14 components with reflection.

Author Manuscript

Power analyses of the datasets
The dataset was subsampled up to the size of 1, 5, 20, 40, 60, 80, 90 and 95 % of the original
dataset. For each subsampled dataset the method estimated mutational components using
svd decompose matrix as input. Recovery quality of a component of the original dataset
in each subsampled dataset was estimated as maximum absolute Pearson correlation across
all inferred components of a subsampled dataset. To account for uncertainty in subsampling
outcome, quality of recovery was averaged across 10 independent sampling runs at each
subsampling depth. Finally, at each subsampling depth we estimated average number of
components 1) having reflection and 2) having highly correlated (>0.75) counterpart in the
original dataset.

Author Manuscript

Comparison of different inference methods.
We compared methods that use decorrelation, independence, and non-negativity as
constraints on matrix factorization problem. PCA was used as a baseline method that
decorrelates mutational components using matrix R of mutation type rates, Z-score
transformed across genomic windows. In case of PCA, mutational components were
interpreted as rows of orthogonal matrix V (see equation 1). PCA was also used as
a dimensionality reduction approach before ICA. Mutational components that maximize
independence of spectra were obtained as described above, while independence of intensities
was achieved using ICA of orthogonal matrix U (see equation 1).

Author Manuscript

On the other hand, non-negative matrix factorization (NMF) approach was applied to the
matrix of mutation type rates with each mutation type rate normalized by its genome-wide
average level. Using NMF R package we run standard NMF algorithm (option ‘brunet’),
NMF that tends to produce sparser components (option ‘ns-NMF’, default parameters)
and NMF that tends to diversify expression of components patterns (option ‘pe-NMF’,
parameters: alpha=0.01, beta=1). Since we noticed that for this TOPMed dataset NMF tends
to converge to different local optima, each NMF algorithm was run using 10 starting points,
including ‘nnsvd’, ‘ica’ and 8 ‘random’ options. To make analysis of NMF components
compatible with that of PCA and ICA, NMF-inferred components were centered by
subtracting 1 (normalized genome-wide average rates). All of the methods were run using
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dimensionality of 14 of input components. Components that have spectra dominated by
a single outlier mutation type, that is 10 times exceeding loadings of any other mutation
types, were removed. Reflection test with cutoff of 0.75 on reflection correlation was used to
estimate the number of potential biological components for each method.
Statistical properties of mutational components
The scale of mutational components was defined using a linear autoregressive model. The
spatial intensity of each mutational component was modeled as:
Ip =

M

∑

k=1

ak ⋅ I p − k + ξp,

Author Manuscript

where Ip is the intensity at position p, ak are autoregressive coefficients and ξp is the residual
noise. Order M of the model was chosen using Akaike Information Criterion. The R package
ar was used to fit the autoregressive model. The scale of each process was defined as the
half-life of the autoregressive model
ℎl =

ln(0.5)
M
ln(∑k = 1 ak . )

The contribution of each component was defined as the squared sum of intensities.
Contributions of all components were then scaled to the unit sum.
Assessment of components robustness

Author Manuscript

Robustness of each component spectrum was assessed using a bootstrap of genomic
windows. 500 sets of 14 components were inferred using a bootstrap of windows.
Maximum Spearman correlations between an original component and the components in
each bootstrapped set were calculated to provide estimates of the similarity of potentially
identical components. For all mutational components, average Spearman correlations of the
spectra with bootstrapped components were above 0.68, indicating the robustness of spectra
estimates.

Author Manuscript

Inference of components was repeated for a window size of 5 kb and 30 kb to explore
robustness with respect to window size. For each window choice, the procedure of inference
was repeated independently, including selection of the optimal number of components. The
spectra of all original components were recapitulated, with a correlation of more than 0.64 in
at least one of two runs. Finally, component spectra were compared between TOPMed and
gnomAD datasets. For that, the procedure of components inference, including selection of
the optimal number of components, was repeated for the gnomAD dataset using a window
size of 100 kb. The spectra of most components were recapitulated with a correlation of
more than 0.6, while three components (3, 10, 11) showed moderate correlation (0.46,
0.43, 0.55). Overall, this indicates that components are robust with respect to the choice of
window and dataset.
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To assess if the spatial distribution of de novo mutations is consistent with individual
mutational processes, we pooled 421,106 de novo point mutations from two datasets (3, 4)
and estimated the log ratio of de novo frequencies of mutation types in 25% of genomic
windows of high component intensities relative to frequencies of mutation types in the
whole genome. Consistency of de novo data with the mutational component is quantified
as the Spearman correlation between this log ratio for de novo mutations and the spectrum
of the corresponding mutational component. Spearman correlations were positive for each
component. To estimate the uncertainty of these correlations, we repeated the estimation
of Spearman correlations multiple times using bootstrapped sets of genomic windows. The
significance of each association was assessed as the p-value of zero correlation relative
to the distribution of bootstrapped Spearman correlations. The results show that for all
components the correlation is significantly consistent (p < 0.05; Supplementary Figure 1).
To assess parent-specific effects, the Spearman correlation between the log ratio of de novo
mutation frequencies and the spectrum of mutational process was estimated separately for
phased maternal and paternal de novo mutations. Before this procedure, 63,387 paternal de
novo mutations were downsampled to match the size of 17,406 maternal de novo mutations.
The distribution of differences between maternal and paternal Spearman correlations
was constructed using a bootstrap of genomic windows to assess statistical significance,
estimated as the p-value of zero correlation relative to the bootstrapped distribution.
Similarly, to assess age effects of mutational processes, the dataset was partitioned by
the average age of parents in two equal parts of young and old parents and the procedure
identical to that applied for parent-specific effects was repeated.
Simulations to assess the limitations of the approach

Author Manuscript
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The ability to infer spatially-varying mutational processes depends on their statistical
properties, such as spatial scale, degree of variability along the genome and degeneracy
of mutational spectrum. Limitations of inference with respect to these statistical properties
were analyzed through simulations of mutational processes underlying spatially variable
mutation rates. Briefly, we simulated spectra and intensities of 14 mutational components
corresponding to 4 strand-independent and 5 strand-dependent processes (4·1 and 5·2
components respectively), linearly combined them to obtain variable mutation type rates
along the genome and sampled mutation counts using Poisson process. Then the procedure
of spatial inference was made for the matrix of simulated mutation counts and spectra of
inferred components were compared to simulated ones to estimate quality of recovery.
Recovery quality of a simulated component was calculated as a maximum absolute
Pearson correlation to inferred components. Simulations were repeated 8000 times to assess
processes in a wide range of scales, loadings and spectra degeneracies.
In more detail, intensities of components were simulated by continuous Ornstein-Uhlenbeck
(O-U) processes. Scale of component was estimated as half-life (hl) of O-U process. The
latter was sampled from 100 bp to 200 kb uniformly at log scale. Stationary O-U mean
m (see equation 2) was assigned to 3 and stationary variance α was sampled from 0.005
to 5 uniformly at log scale. Stationary variance controls the degree of spatial variability of
components. Overall, intensities I were modeled using O-U diffusion:
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dI = λ ⋅ (m − I) ⋅ dp + σ ⋅ N(0, 1),
where p is genomic position, λ is a rate of reversion

log(2)
, σ = 2 ⋅ α ⋅ λ,
ℎl

(2)

α = exp(unif(log(5 ·

10−3), log(5))), m = 3.
Rate vector of 192 mutation types was sampled using Dirichlet distribution S = Dir(α ⋅ 1 )
with a concentration parameter α sampled uniformly from 0.01 to 10 at log scale.
Concentration parameter controls degeneracy of spectra and is shown in Supplementary
Fig. 1a as a “spectra degeneracy” score. Mutation type rates of components spectra were
then re-normalized to match the average observed genome-wide mutation frequencies in
TOPMed. Rates Si,j of each spectra mutation type j were scaled by a factor cj: Si,j ← Si,j

Author Manuscript

· cj, where cj =

μj
∑i 〈Ii〉 ⋅ Si, j

with μj being average genome-wide mutation rate of type j and

⟨Ii⟩ is average intensity of a process i. Finally, expected mutation rates of each type j in
each window w is a linear combination of components vw,j = Σi Iwi · Sij. Mutation counts
of each type in each window were sampled from Poisson process with a rate mw,j = vw,j ·
cj proportional to mutation rate vw,j and average number of available cj context triplets per
window in the human genome. The procedure of components inference was then applied to
matrix mw,j of simulated mutation counts.
Associations with epigenetic tracks and DNA features
We relied on the analysis of correlations between mutational processes and epigenomic
tracks to gain insight into biological mechanisms.

Author Manuscript

Replication timing was obtained from (5). In the absence of data from the relevant germline
tissue, we used the track for Mcf7 cells. The results were insensitive to the choice of cell
type. Replication fork direction was determined as in (6).
Gene coordinates were obtained from the ‘knownGenes’ track downloaded from the UCSC
genome browser. We measured gene bias within each window as the number of nucleotides
transcribed on the reference strand minus the number of nucleotides transcribed on the
strand complementary to the reference. Correlations with process 6/7 asymmetry, estimated
as the difference in intensities of components 6 and 7, were calculated only in regions of
high intensity of process 6/7 (component 6 + component 7 intensity >1.4).
Methylation level for each CpG dinucleotide were obtained from (7) and the methylation
level of a window was calculated as a mean across all CpG sites within it.
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Hydroxymethylation data was obtained from (8). Because this track is very sparse, similarly
to previous study (9), we considered any CpG site with the fraction of hydroxymethylated
reads exceeding 0.1 as hydroxymethylated. The hydroxymethylation level of a window
was calculated as the fraction of hydroxymethylated CpG dinucleotides among all CpG
dinucleotides.
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Histone modifications H3k4me3, H3k27ac and H3k4me1 were downloaded from the
UCSC genome browser. These tracks were obtained for human embryonic stem cells as
a potentially relevant cell type.
Sex-specific recombination rate were obtained from (3).
CpG islands coordinates were downloaded from UCSC genome browser.
Correlations between all tracks and mutational processes are listed in Supl. Table 1.
Associations with the activity of nucleotide excision repair
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Nucleotide excision repair (NER) effectively removes bulky lesions and its activity is partly
governed by chromatin structure (10). Kinetics of CPD and 6-4PP repair by NER was
measured in (11). Repair of 6-4PP occurs within less than an hour and thus is unlikely
to be relevant for the mutagenesis that operates in the germline, because divisions of
spermatogonia take many days and the dictate phase of oogenesis lasts for many years.
Therefore, we focused on the repair of CPDs, a much slower process (11). The majority of
UV-induced lesions occur in TT dinucleotides due to properties of UV radiation. To account
for this bias, we normalized NER activity to TT dinucleotide content. Following this, we
correlated NER efficiency with the intensity of each mutational process.
On the other hand, local activity of NER should be inverse to the amount of the damage
that remains in DNA after 48 hours past UV-irradiation. We correlated mutational processes
with the amount of unrepaired CPD damage (12), normalized to TT dinucleotide content.
Correlations between NER activity and mutational processes are shown in Fig. S4.
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Clustered de novo mutations
In line with previous studies, we defined clustered de novo mutations as pairs of mutations
observed in the same individual at distances less than 20,000 nucleotides (13, 14). De novo
mutations were obtained from (3) and entire clusters were attributed to be of maternal or
paternal origin if there was at least one phased mutation of this origin. Clusters that have
mutations on both the paternal and maternal haplotype were excluded.
Alteration of mutation rate in gene bodies

Author Manuscript

To directly estimate the effect of transcription on mutation rate, we compare the mutation
rate for each of 12 mutation types on the non-transcribed strand of the gene to the mutation
rate 100 KB upstream and downstream of the gene (Fig. 3G and Suppl. Fig. S5). To
reliably estimate the intensity of the process and the mutation rate within genes, only
genes longer than 100 KB were considered. Differences in mutation rate between the
gene and flanking region were normalized to the genome-average mutation rate for each
corresponding mutation type.
Maternal age effect in regions susceptible to process 6/7
“Maternal regions” were determined by the high intensity of component 6 + component
7. To choose the threshold for this sum, we compared quintiles of the distribution of
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component 6 + component 7 to that of the normal distribution and the deviated right tail of
8601 windows was used to define “maternal regions” (Fig. S.5).
To calculate the effect of maternal age, Broyden–Fletcher–Goldfarb–Shanno maximum
likelihood algorithm was used (R package bbmle). We deal with the uncertainty contributed
by non-phased mutations as in (15).
Effect of transcription binding sites on mutation rate
Aggregate ChIP-seq peaks were obtained from ReMap2018 (16). CpG islands were
excluded from the following analysis.
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Mutation rate for the set of transcription factor binding sites was calculated in overlapping
100 nucleotide-long sliding windows for each trinucleotide context, then this rate was
normalized on genome average mutation rate values and combined into the stated categories
using a weighted average.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig 1. Inference of spatially-varying mutational processes in germline.
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(A) Observed spatial variability of mutational spectrum is modeled as a number of
mutational processes with specific spectra and spatially-varying intensities.
(B) Strand-independent mutational processes have equal rates of complementary mutations
at each locus. Strand-dependent mutational processes produce two unequal patterns of
complementary mutation rates at loci depending on the strand orientation of a genomic
feature.
(C) Example of a predicted strand-independent process. Loadings of complementary
mutations of mutational component 9 are highly similar.
(D) Example of a predicted strand-dependent process. Loadings of complementary
mutations between two mutational components 1 and 2 are highly similar and characterize
a single mutational process (left). In contrast to strand-independent process (see Fig.
1C), loadings of complementary mutations of mutational component 1 (upper right) and
component 2 (lower right) are almost uncorrelated.
(E) Theoretical scale-loading limitations for detection of mutational processes shows
potentially high range of processes that can be recovered with the proposed approach.
Simulations of mutational processes at different scales (quantified as half-life of simulated
Ornstein-Uhlenbeck process) and spatial loadings (fraction of spatially-varying mutations of
a process among total mutations, scheme) were based on parameters from TOPmed dataset.
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Quality of recovery was assessed using maximum absolute correlation between spectra of
each simulated component and reconstructed components.
(F) Reflection matrix reveals strand-dependency of processes and separates biological
signal from noise. Correlation of spectrum of one mutational component with reverse
complementary spectrum of another demonstrates clear separation into self-correlated
components (5,8, 9,14) and pairs of mutually correlated components (1/2, 3/4, 6/7, 10/11,
12/13).
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Fig 2. Mutational processes are associated with distinct genomic features.
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(A) Heatmap of correlations of intensities with genome features shows diverse modes
of associations (left). For strand-dependent processes two spatial characteristics were
considered: intensity (int.), estimated as the sum of intensities of two components, and
asymmetry (as.), estimated as the difference between intensities of two components.
Fraction of mutational variance explained by each process (middle) and scale, estimated
as the half-life of the autoregressive model (right) are shown.
(B) (top) The spectrum of one of the two components comprising process 1/2; (bottom)
An example of intensities of components 1 and 2, associated with non-transcribed strands
on chromosome 1. The bars on the bottom of the panel depict gene bodies (colors: cyan if
transcribed strand is the reference strand and orange otherwise).
(C) (top) The spectrum of one of the two components comprising process 3/4; (bottom) The
association between the asymmetry of process 3/4 (component 3 – component 4) and the
direction of the replication fork measured as a gradient of replication timing.
(D) The spectrum of component 5 (top), and its association with replication timing (bottom).
(E) (top) The spectrum of component 10; (bottom) Intensity of component 10 among 13
consecutive 10 KB-long regions adjacent to the transcription end site (TES). Box plot shows
component 10 intensity. Mean intensity of component 10 in each region shown as a red
point. Mean fraction of the transcribed nucleotides per region shown on the bottom.
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Fig 3. Oocyte-specific mutational process.
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(A) The spectrum of one of the two components comprising process 6/7.
(B and C) Examples of two loci with high intensity of process 6/7, estimated as the sum of
intensities of component 6 and component 7. Black dots on top of the panels mark windows
of high intensity that we call “maternal regions” (see Methods). Red dots show de novo
maternal clustered mutations from Halldorsson et al. (18).
(D) Enrichment of maternal clustered de novo mutations from Halldorsson et al. in maternal
regions. The fraction of each chromosome that is attributed to “maternal regions” (high
intensity of process 6/7) is shown in black. The fraction of maternal clustered mutations
located within maternal regions on each chromosome is shown in red; the difference in size
between the red and black bars indicates enrichment of clustered mutations within “maternal
regions”.
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(E and F) Zoom in view of process 6/7 intensity spikes around FHIT and CSMD1 genes on
non-transcribed strands. Bars on the bottom depict gene bodies (colors: cyan if transcribed
strand is the reference strand and orange otherwise).
(G) Difference between C>G mutation rate on transcribed or non-transcribed strand of a
gene compared to a 100 KB region flanking the gene. Red dots correspond to genes within
maternal regions and black dots corresponds to genes outside of maternal regions. Density
plots on the top and right summarize the distributions on the X and Y axes.
(H) Ratio of parent-specific de novo mutation rates between first and last parent age
quartiles is shown, estimated independently for “maternal regions” and for the rest of the
genome. The error bars show the 95% confidence interval (95% CI) for the ratio of two
binomial proportions test.
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Fig 4. Cytosine deamination and cytosine demethylation.
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(A and D) The mutational spectrum of component 8 is dominated by CpG>TpG (top), while
component 9 is dominated by CpG>GpG and CpG>ApG (bottom).
(B, C, E and F) Association between the intensity of components 8 and 9 and cytosine
methylation or cytosine hydroxymethylation.
(G) Process 8 is inversely correlated with the density of CpG islands, while process 9 is
positively correlated. Blue dots represent density of CpG islands across a 50 MB long region
of chromosome 5.
(H) Effect of CpG islands on mutation rate in CpG context and in cytosines outside of CpG
context.
(I) Mutation rate in CpG context at transcription factor binding sites located outside of
annotated CpG islands, as determined by ChIP-seq peaks (see Methods), normalized to the
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genome average mutation rate. 95% binomial proportion confidence intervals are displayed
in transparent lines. Higher levels of demethylation at these sites lead to the accelerated rate
of CpG transversions.
(J) Illustration of the biochemical mechanisms suggested for processes 8 and 9. Enzymatic
oxidation of methylcytosine (5-mC) leads to hydroxymethylcytosine (5-hmC) (35), which
after additional steps of oxidation should be removed by glycosylase, leaving an abasic
site (AP). During DNA replication, AP sites will frequently be converted to CpG>GpG
mutations and more rarely to CpG>ApG mutations, matching the spectra of process 9 (36).
Alternatively, successful repair of AP sites creates non-methylated cytosines. Alternately,
spontaneous deamination of methylcytosine creates a T to G mismatch, enhancing the rate
of CpG>TpG mutations. While deamination should be prevalent in CpG sites with high
methylation levels, the mutagenic effect of demethylation should be prominent in CpG
islands.
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